{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:11:23Z","timestamp":1784819483999,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K08178"],"award-info":[{"award-number":["19K08178"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The association between <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose (<jats:sup>18<\/jats:sup>F-FDG) myocardial uptake and clinical presentations in cardiac sarcoidosis (CS) has not yet been clarified. The Patlak slope, Ki<jats:italic>,<\/jats:italic> which represents the rate of <jats:sup>18<\/jats:sup>F-FDG uptake is a quantitative index of <jats:sup>18<\/jats:sup>F-FDG metabolism. This study aims to investigate the usefulness of standardized uptake value (SUV) and Patlak Ki images (Ki images) extracted from dynamic <jats:sup>18<\/jats:sup>F-FDG-PET\/CT for evaluating the risk of clinical events (CEs) in CS. The SUV and Ki myocardial images were generated from 30 dynamic <jats:sup>18<\/jats:sup>F-FDG-PET\/CT scans of 21 CS patients. The SUV and Ki images both were rated as positive in 19 scans and negative in 11 scans with the same incidence of CEs which were significantly higher in positive than negative scans [cardiac dysfunction: 78.9% (15\/19) vs. 27.2% (3\/11); arrhythmic events: 65.5% (10\/19) vs. 0% (0\/11)]. In 19 positive scans, the three Ki parameters (Ki max, Ki mean and Ki volume) were significantly higher in scans for patients with arrhythmic events than in those without. Logistic regression analysis showed that the Ki volume alone was significantly associated with the risk of arrhythmic events. Our study suggests that Ki images may add value to SUV images for evaluating the risk of CEs in CS patients.<\/jats:p>","DOI":"10.1038\/s41598-021-82217-0","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T11:06:44Z","timestamp":1612177604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Value of Patlak Ki images from 18F-FDG-PET\/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Masatoyo","family":"Nakajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Jinguji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Kubozono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"key":"82217_CR1","first-page":"50","volume":"6","author":"E Hulten","year":"2016","unstructured":"Hulten, E. et al. Cardiac sarcoidosis: State of the art review. Cardiovasc. Diagn. Ther. 6, 50\u201363 (2016).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"82217_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1136\/hrt.2005.080481","volume":"92","author":"AR Doughan","year":"2006","unstructured":"Doughan, A. R. & Williams, B. R. Cardiac sarcoidosis. Heart 92, 282\u2013288 (2006).","journal-title":"Heart"},{"key":"82217_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman, K. J., Hutchins, G. M. & Bulkley, B. H. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58, 1204\u20131211 (1978).","journal-title":"Circulation"},{"key":"82217_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","volume":"63","author":"WC Roberts","year":"1977","unstructured":"Roberts, W. C., McAllister, H. A. Jr. & Ferrans, V. J. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am. J. Med. 63, 86\u2013108 (1977).","journal-title":"Am. J. Med."},{"key":"82217_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","volume":"278","author":"Y Matsui","year":"1976","unstructured":"Matsui, Y. et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann. N Y Acad. Sci. 278, 455\u2013469 (1976).","journal-title":"Ann. N Y Acad. Sci."},{"key":"82217_CR6","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1378\/chest.07-2784","volume":"133","author":"D Mehta","year":"2008","unstructured":"Mehta, D. et al. Cardiac involvement in patients with sarcoidosis: Diagnostic and prognostic value of outpatient testing. Chest 133, 1426\u20131435 (2008).","journal-title":"Chest"},{"key":"82217_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","volume":"100","author":"NM Gideon","year":"1996","unstructured":"Gideon, N. M. & Mannino, D. M. Sarcoidosis mortality in the United States, 1979\u20131991: An analysis of multiple-cause mortality data. Am. J. Med. 100, 423\u2013427 (1996).","journal-title":"Am. J. Med."},{"key":"82217_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1148\/radiol.2382041977","volume":"238","author":"GK von Schulthess","year":"2006","unstructured":"von Schulthess, G. K., Steinert, H. C. & Hany, T. F. Integrated PET\/CT: Current applications and future directions. Radiology 238, 405\u2013422 (2006).","journal-title":"Radiology"},{"key":"82217_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.crad.2015.03.010","volume":"70","author":"S Vaidyanathan","year":"2015","unstructured":"Vaidyanathan, S., Patel, C. N., Scarsbrook, A. F. & Chowdhury, F. U. FDG PET\/CT in infection and inflammation\u2013current and emerging clinical applications. Clin. Radiol. 70, 787\u2013800 (2015).","journal-title":"Clin. Radiol."},{"key":"82217_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","volume":"3","author":"N Tahara","year":"2010","unstructured":"Tahara, N. et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc. Imaging 3, 1219\u20131228 (2010).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"82217_CR11","first-page":"1571","volume":"47","author":"Y Nishiyama","year":"2006","unstructured":"Nishiyama, Y. et al. Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis. J. Nucl. Med. 47, 1571\u20131576 (2006).","journal-title":"J. Nucl. Med."},{"key":"82217_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0969-8051(00)00155-4","volume":"27","author":"SC Huang","year":"2000","unstructured":"Huang, S. C. Anatomy of SUV. Standardized uptake value. Nucl. Med. Biol. 27, 643\u2013646 (2000).","journal-title":"Nucl. Med. Biol."},{"key":"82217_CR13","first-page":"1308","volume":"35","author":"LM Hamberg","year":"1994","unstructured":"Hamberg, L. M. et al. The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification?. J. Nucl. Med. 35, 1308\u20131312 (1994).","journal-title":"J. Nucl. Med."},{"key":"82217_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak, C. S., Blasberg, R. G. & Fenstermacher, J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3, 1\u20137 (1983).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"82217_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","volume":"5","author":"CS Patlak","year":"1985","unstructured":"Patlak, C. S. & Blasberg, R. G. Graphical evaluation of blood-tobrain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 5, 584\u2013590 (1985).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"82217_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1148\/radiology.189.3.8234714","volume":"189","author":"KR Zasadny","year":"1993","unstructured":"Zasadny, K. R. & Wahl, R. L. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: Variations with body weight and a method for correction. Radiology 189, 847\u2013850 (1993).","journal-title":"Radiology"},{"key":"82217_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1148\/radiology.213.2.r99nv37521","volume":"213","author":"Y Sugawara","year":"1999","unstructured":"Sugawara, Y. et al. Reevaluation of the standardized uptake value for FDG: Variations with body weight and methods for correction. Radiology 213, 521\u2013525 (1999).","journal-title":"Radiology"},{"key":"82217_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00259-002-0981-4","volume":"30","author":"NM Freedman","year":"2003","unstructured":"Freedman, N. M. et al. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur. J. Nucl. Med. Mol. Imaging 30, 46\u201353 (2003).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"82217_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12149-018-1250-3","volume":"32","author":"A Lebasnier","year":"2018","unstructured":"Lebasnier, A. et al. Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis. Ann. Nucl. Med. 32, 319\u2013327 (2018).","journal-title":"Ann. Nucl. Med."},{"key":"82217_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.111.090662","volume":"53","author":"G Youssef","year":"2012","unstructured":"Youssef, G. et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and metaanalysis including the Ontario experience. J. Nucl. Med. 53, 241\u2013248 (2012).","journal-title":"J. Nucl. Med."},{"key":"82217_CR21","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","volume":"4","author":"K Banba","year":"2007","unstructured":"Banba, K. et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm. 4, 1292\u20131299 (2007).","journal-title":"Heart Rhythm."},{"key":"82217_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","volume":"6","author":"BA Mc Ardle","year":"2013","unstructured":"Mc Ardle, B. A. et al. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-fluorodoexyglucose positron emission tomography?. Circ. Cardiovasc. Imaging 6, 617\u2013626 (2013).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"82217_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","volume":"21","author":"A Ahmadian","year":"2014","unstructured":"Ahmadian, A. et al. Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J. Nucl. Cardiol. 21, 925\u2013939 (2014).","journal-title":"J. Nucl. Cardiol."},{"key":"82217_CR24","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.118.035032","volume":"138","author":"LE Swart","year":"2018","unstructured":"Swart, L. E. et al. Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography in prosthetic heart valve endocarditis. Circulation 138, 1412\u20131427 (2018).","journal-title":"Circulation"},{"key":"82217_CR25","first-page":"928","volume":"18","author":"Q Wang","year":"2013","unstructured":"Wang, Q., Wang, R. F., Zhang, J. & Zhou, Y. Differential diagnosis of pulmonary lesions by parametric imaging in (18)F-FDG PET\/CT dynamic multi-bed scanning. J. BUON. 18, 928\u2013934 (2013).","journal-title":"J. BUON."},{"key":"82217_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1102\/1470-7330.2012.0033","volume":"12","author":"A Dimitrakopoulou-Strauss","year":"2012","unstructured":"Dimitrakopoulou-Strauss, A., Pan, L. & Strauss, L. G. Quantitative approaches of dynamic FDG-PET and PET\/CT studies (dPET\/CT) for the evaluation of oncological patients. Cancer Imaging 12, 283\u2013289 (2012).","journal-title":"Cancer Imaging"},{"key":"82217_CR27","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2967\/jnumed.109.065243","volume":"50","author":"D Vriens","year":"2009","unstructured":"Vriens, D. et al. A Curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment. J. Nucl. Med. 50, 1933\u20131939 (2009).","journal-title":"J. Nucl. Med."},{"key":"82217_CR28","first-page":"1622","volume":"42","author":"AP van der Weerdt","year":"2001","unstructured":"van der Weerdt, A. P. et al. Image-derived input functions for determination of MRGlu in cardiac 18F-FDG PET scans. J. Nucl. Med. 42, 1622\u20131629 (2001).","journal-title":"J. Nucl. Med."},{"key":"82217_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40658-020-00330-x","volume":"7","author":"M Naganawa","year":"2020","unstructured":"Naganawa, M. et al. Assessment of population-based input functions for Patlak imaging of whole body dynamic 18F-FDG PET. EJNMMI Phys. 7, 67 (2020).","journal-title":"EJNMMI Phys."},{"key":"82217_CR30","first-page":"2008","volume":"45","author":"M Lubberink","year":"2004","unstructured":"Lubberink, M. et al. Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET. J. Nucl. Med. 45, 2008\u20132015 (2004).","journal-title":"J. Nucl. Med."},{"key":"82217_CR31","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1088\/0031-9155\/60\/15\/5733","volume":"60","author":"S Ahn","year":"2015","unstructured":"Ahn, S. et al. Quantitative comparison of OSEM and penalized likelihood image reconstruction using relative difference penalties for clinical PET. Phys. Med. Biol. 60, 5733\u20135751 (2015).","journal-title":"Phys. Med. Biol."},{"key":"82217_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejmp.2017.09.124","volume":"42","author":"K Wagastuma","year":"2017","unstructured":"Wagastuma, K. et al. Comparison between new-generation SiPM-based and conventional PMT-based TOF-PET\/CT. Phys. Med. 42, 203\u2013210 (2017).","journal-title":"Phys. Med."},{"key":"82217_CR33","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki, F. et al. JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis\u2014digest version. Circ. J. 83, 2329\u20132388 (2019).","journal-title":"Circ. J."},{"key":"82217_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-4-1","volume":"4","author":"M Morooka","year":"2014","unstructured":"Morooka, M. et al. Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res. 4, 1 (2014).","journal-title":"EJNMMI Res."},{"key":"82217_CR35","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","volume":"45","author":"D Muser","year":"2018","unstructured":"Muser, D. et al. Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia. Eur. J. Nucl. Med. Mol. Imaging 45, 1394\u20131404 (2018).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"82217_CR36","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","volume":"131","author":"R Kandolin","year":"2015","unstructured":"Kandolin, R. et al. Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 131, 624\u2013632 (2015).","journal-title":"Circulation"},{"key":"82217_CR37","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.mayocp.2016.05.013","volume":"91","author":"G Sinagra","year":"2016","unstructured":"Sinagra, G. et al. Myocarditis in clinical practice. Mayo Clin. Proc. 91, 1256\u20131266 (2016).","journal-title":"Mayo Clin. Proc."},{"key":"82217_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1148\/radiology.208.2.9680575","volume":"208","author":"K Oppo","year":"1998","unstructured":"Oppo, K. et al. Doppler perfusion index: An inter-observer and intra-observer reproducibility study. Radiology 208, 453\u2013457 (1998).","journal-title":"Radiology"},{"key":"82217_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"327","author":"JM Bland","year":"1986","unstructured":"Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327, 307\u2013310 (1986).","journal-title":"Lancet"},{"key":"82217_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335 (1950).","journal-title":"Cancer"},{"key":"82217_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1998","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44, 837\u2013845 (1998).","journal-title":"Biometrics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82217-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:49:49Z","timestamp":1670035789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82217-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82217"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82217-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"4 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict interest except employment by GE Healthcare Japan (Hirofumi Kawakami and Akira Hirayama). The Kagoshima University Department of Radiology received the technical support from GE Healthcare Japan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2729"}}